DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 967 filers reported holding DANAHER CORPORATION in Q2 2015. The put-call ratio across all filers is 0.93 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $20,083,000 | -16.3% | 234,808 | -23.9% | 0.60% | -20.0% |
Q4 2016 | $24,003,000 | +5.1% | 308,367 | +5.8% | 0.75% | +6.3% |
Q3 2016 | $22,838,000 | -19.8% | 291,337 | +3.3% | 0.71% | -26.0% |
Q2 2016 | $28,489,000 | +9.7% | 282,067 | +3.0% | 0.96% | +11.4% |
Q1 2016 | $25,978,000 | +24.1% | 273,852 | +21.5% | 0.86% | +19.1% |
Q4 2015 | $20,928,000 | +427.6% | 225,324 | +384.0% | 0.72% | +468.5% |
Q3 2015 | $3,967,000 | +6.0% | 46,554 | +6.5% | 0.13% | +8.5% |
Q2 2015 | $3,743,000 | +62.2% | 43,731 | +60.9% | 0.12% | +62.5% |
Q1 2015 | $2,307,000 | -0.9% | 27,175 | 0.0% | 0.07% | +4.3% |
Q4 2014 | $2,329,000 | +12.8% | 27,175 | 0.0% | 0.07% | +263.2% |
Q3 2014 | $2,065,000 | +6.3% | 27,175 | +10.2% | 0.02% | -68.9% |
Q2 2014 | $1,942,000 | +18.3% | 24,665 | +12.7% | 0.06% | +8.9% |
Q1 2014 | $1,641,000 | +6.8% | 21,883 | +9.9% | 0.06% | +3.7% |
Q4 2013 | $1,537,000 | -82.7% | 19,915 | -84.5% | 0.05% | -84.2% |
Q3 2013 | $8,908,000 | -9.6% | 128,506 | -17.5% | 0.34% | -9.8% |
Q2 2013 | $9,857,000 | – | 155,711 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |